| 1 | PRAX | Praxis Precision Medicines, Inc. | 4.97% |
| 2 | AXSM | Axsome Therapeutics, Inc. | 4.86% |
| 3 | ALKS | Alkermes plc | 4.63% |
| 4 | SRRK | Scholar Rock Holding Corporation | 3.91% |
| 5 | PTCT | PTC Therapeutics, Inc. | 3.88% |
| 6 | BIIB | Biogen Inc. | 3.81% |
| 7 | ARGX | argenx SE | 3.68% |
| 8 | ACAD | ACADIA Pharmaceuticals Inc. | 3.67% |
| 9 | DNLI | Denali Therapeutics Inc. | 3.64% |
| 10 | XENE | Xenon Pharmaceuticals Inc. | 3.64% |
| 11 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.53% |
| 12 | NBIX | Neurocrine Biosciences, Inc. | 3.48% |
| 13 | SUPN | Supernus Pharmaceuticals, Inc. | 3.46% |
| 14 | CNTA | Centessa Pharmaceuticals plc | 3.10% |
| 15 | KRX: 326030 | SK Biopharmaceuticals Co., Ltd. | 3.05% |
| 16 | EWTX | Edgewise Therapeutics, Inc. | 2.85% |
| 17 | SRPT | Sarepta Therapeutics, Inc. | 2.72% |
| 18 | AVDL | Avadel Pharmaceuticals plc | 2.61% |
| 19 | DYN | Dyne Therapeutics, Inc. | 2.43% |
| 20 | DNTH | Dianthus Therapeutics, Inc. | 2.43% |
| 21 | HLUNB.CO | H. LUNDBECK CLASS B | 2.31% |
| 22 | AXGN | Axogen, Inc. | 1.98% |
| 23 | STO: BIOA.B | BioArctic AB (publ) | 1.83% |
| 24 | BHVN | Biohaven Ltd. | 1.70% |
| 25 | ASX: NEU | Neuren Pharmaceuticals Limited | 1.65% |
| View IBRN holdings |
